Form4insider filings, from the source

SEC Form 4 · accession 0001127602-15-026159

PALL CORP · PLL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Yves Baratelli
Officer — President, Pall Life Sciences
Period of report
Aug 31, 2015
Accepted (ET)
Aug 31, 2015 · 2:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000075829

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Aug 31, 2015D5,638$127.20D0D
Common StockF2Aug 31, 2015D17,449—D0D
Common StockF3Aug 31, 2015D44,987$127.20D0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F4$59.75Aug 31, 2015D5,178D—Jan 18, 2019Common Stock5,1780D
Employee Stock Option (Right to Buy)F5$64.80Aug 31, 2015D9,506D—Jan 16, 2020Common Stock9,5060D
Employee Stock Option (Right to Buy)F6$82.47Aug 31, 2015D9,969D—Dec 11, 2020Common Stock9,9690D
Employee Stock Option (Right to Buy)F7$94.53Aug 31, 2015D14,085D—Dec 10, 2021Common Stock14,0850D

Explanation of responses